These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Lopez LR; Simpson DF; Hurley BL; Matsuura E Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973 [TBL] [Abstract][Full Text] [Related]
23. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices. Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664 [TBL] [Abstract][Full Text] [Related]
24. High-sensitivity C-reactive protein: discriminator between patients with primary and secondary antiphospholipid syndrome. Bećarević M; Majkić-Singh N Clin Biochem; 2008 Dec; 41(18):1449-53. PubMed ID: 18801352 [TBL] [Abstract][Full Text] [Related]
25. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539 [TBL] [Abstract][Full Text] [Related]
26. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Morgan PE; Sturgess AD; Davies MJ Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354 [TBL] [Abstract][Full Text] [Related]
27. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome]. Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045 [TBL] [Abstract][Full Text] [Related]
28. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471 [TBL] [Abstract][Full Text] [Related]
29. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Mahmoud RA; El-Gendi HI; Ahmed HH Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275 [TBL] [Abstract][Full Text] [Related]
30. Angiogenic activity in sera of patients with systemic lupus erythematosus. Sakly N; Mirshahi P; Ducros E; Soria J; Ghedira I; Mirshahi M Lupus; 2009 Jul; 18(8):705-12. PubMed ID: 19502266 [TBL] [Abstract][Full Text] [Related]
31. [Mutation of a 5,10-methylenetetrahydrofolate reductase gene in systemic lupus erythematosis and antiphospholipid syndrome]. Reshetniak TM; Patrushev LI; Tikhonova TF; Kovalenko TF; Mach ES; Aleksandrova EN; Miroshnikov AI; Nasonova VA Ter Arkh; 2002; 74(5):28-32. PubMed ID: 12087901 [TBL] [Abstract][Full Text] [Related]
32. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese. Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345 [TBL] [Abstract][Full Text] [Related]
33. Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus. Martin-Rodriguez S; Reverter JC; Tàssies D; Espinosa G; Heras M; Pino M; Escolar G; Diaz-Ricart M Lupus; 2015 Oct; 24(11):1143-9. PubMed ID: 25824235 [TBL] [Abstract][Full Text] [Related]
34. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371 [TBL] [Abstract][Full Text] [Related]
35. [The role of mannose binding lectin in the pathogenesis of systemic lupus erythematosus]. Li SG; Huang F; Liu XY; Deng XX; Xu M; Cong XZ; Ding YZ; Guo JH; Deng XH; Zhao MS Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):463-7. PubMed ID: 16677572 [TBL] [Abstract][Full Text] [Related]
36. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Avcin T; Silverman ED Lupus; 2007; 16(8):627-33. PubMed ID: 17711899 [TBL] [Abstract][Full Text] [Related]
37. Serum amyloid A in autoimmune thrombosis. Sodin-Semrl S; Zigon P; Cucnik S; Kveder T; Blinc A; Tomsic M; Rozman B Autoimmun Rev; 2006 Nov; 6(1):21-7. PubMed ID: 17110312 [TBL] [Abstract][Full Text] [Related]
38. Complement activation in patients with primary antiphospholipid syndrome. Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630 [TBL] [Abstract][Full Text] [Related]
39. [Budd-Chiari syndrome and severe thrombocytopenia in a patient with Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome]. Duarte C; Couto M; Inês L; Malcata A Acta Reumatol Port; 2007; 32(2):175-80. PubMed ID: 17576398 [TBL] [Abstract][Full Text] [Related]